Conditional immortalization of cells
US6399384B1 · kind B1 · utility
22Cited by
2References
14Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Sep 15, 2000 |
| Grant date | Jun 4, 2002 |
| Priority date | — |
| Expiry date | Sep 15, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A recombinant, or genetically engineered, mammalian cell, comprises a conditionally-inducible oncogene and an exogenous polynucleotide encoding the catalytic sub-unit of the telomerase complex. The recombinant cells are useful in therapy, to replace lost or damaged cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.